Global Obstetrics Partnering Directory 2018

Dublin, March 15, 2018 -- The "Global Obstetrics Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Global Obstetrics Partnering 2012 to 2018 provides the full collection of Obstetrics disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

The report takes readers through the comprehensive Obstetrics disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Obstetrics deals.

The report presents financial deal terms values for Obstetrics deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In addition, a comprehensive appendix is provided with each report of all Obstetrics partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Obstetrics partnering and dealmaking since 2012.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Obstetrics technologies and products.

Report scope

Global Obstetrics Partnering 2012 to 2018 includes:

• Trends in Obstetrics dealmaking in the biopharma industry since 2012
• Analysis of Obstetrics deal structure
• Access to headline, upfront, milestone and royalty data
• Access to hundreds of Obstetrics deal contract documents
• Comprehensive access to over 3500 Obstetrics deal records
• The leading Obstetrics deals by value since 2012
• Most active Obstetrics dealmakers since 2012

The report includes deals for the following indications: Analgesia in labour, Breastfeeding, Fetal abnormalities, Gestational diabetes, Hemorrhage, Hemolytic disease of the newborn, Hypertension in pregnancy, Labour induction, Nausea, Pre-eclampsia, Prenatal screening, Pregnancy, Ectopic, Hydatiform mole, Miscarriage, Termination, Preterm labour, Vomiting, plus other obstetric indications.

In Global Obstetrics Partnering 2012 to 2018, available deals and contracts are listed by:

• Headline value
• Upfront payment value
• Royalty rate value
• Stage of development at signing
• Deal component type
• Technology type
• Specific therapy indication
  

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Obstetrics dealmaking

2.1. Introduction
2.2. Obstetrics partnering over the years
2.3. Obstetrics partnering by deal type
2.4. Obstetrics partnering by industry sector
2.5. Obstetrics partnering by stage of development
2.6. Obstetrics partnering by technology type
2.7. Obstetrics partnering by therapeutic indication

Chapter 3 - Financial deal terms for Obstetrics partnering

3.1. Introduction
3.2. Disclosed financials terms for Obstetrics partnering
3.3. Obstetrics partnering headline values
3.4. Obstetrics deal upfront payments
3.5. Obstetrics deal milestone payments
3.6. Obstetrics royalty rates

Chapter 4 - Leading Obstetrics deals and dealmakers

4.1. Introduction
4.2. Most active in Obstetrics partnering
4.3. List of most active dealmakers in Obstetrics
4.4. Top Obstetrics deals by value

Chapter 5 - Obstetrics contract document directory

5.1. Introduction
5.2. Obstetrics partnering deals where contract document available

Chapter 6 - Obstetrics dealmaking by therapeutic target

6.1. Introduction
6.2. Deals by Obstetrics therapeutic target

For more information about this report visit https://www.researchandmarkets.com/research/3hs5c7/global_obstetrics?w=12

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Women's Health